BIVV001, a new class of factor VIII replacement for hemophilia A that is independent of von Willebrand factor in primates and mice
Seth Chhabra, Ekta, Liu, Tongyao, Kulman, John, Patarroyo-White, Susannah, Yang, Buyue, Lu, Qi, Drager, Douglas, Moore, Nancy, Liu, Jiayun, Holthaus, Amy M., Sommer, Jurg M., Ismail, Ayman, Rabinovich, Deana, Liu, Zhan, van der Flier, Arjan, Goodman, Allison, Furcht, Chris, Tie, Mark, Carlage, Tyler, Mauldin, Randy, Dobrowsky, Terrence M., Liu, Zhiqian, Mercury, Oblaise, Zhu, Lily, Mei, Baisong, Schellenberger, Volker, Jiang, Haiyan, Pierce, Glenn F., Salas, Joe, Peters, Robert
Published in Blood (23.04.2020)
Published in Blood (23.04.2020)
Get full text
Journal Article
FORMULATIONS AND SCREENING OF BIOLOGICAL THERAPEUTIC AGENTS
MAULDIN, Randy, ZUNIC, Adnan, GUPTA, Kapil, DIMITROVA, Mariana, SULE, Shantanu, KARPES, Lori, KREBS, Mark
Year of Publication 29.11.2017
Get full text
Year of Publication 29.11.2017
Patent
FORMULATIONS AND SCREENING OF BIOLOGICAL THERAPEUTIC AGENTS
MAULDIN, RANDY, GUPTA, KAPIL, SULE, SHANTANU, KARPES, LORI, KREBS, MARK, DIMITROVA, MARIANA, ZUNIC, ADNAN
Year of Publication 21.07.2016
Get full text
Year of Publication 21.07.2016
Patent